Systemic risk factors associated with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration

Retina

Volumn 33, Issue 4, 2013, Pages 841-845

  Sakurada, Yoichi ^a   Yoneyama, Seigo ^a   Imasawa, Mitsuhiro ^a   Iijima, Hiroyuki ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC GLOMERULONEPHRITIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; INTERVIEW; KIDNEY FAILURE; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; POLYPOIDAL CHOROIDAL VASCULOPATHY; PREVALENCE; QUESTIONNAIRE; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SMOKING;

AGED; CARDIOVASCULAR DISEASES; CHOROID DISEASES; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; JAPAN; KIDNEY FAILURE, CHRONIC; MALE; POLYPS; PREVALENCE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84875934661     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31826ffe9d     Document Type: Article

References (32)

1. Wen F, Chen C, Wu D, Li H.Polypoidal choroidal vasculopathy in elderly Chinese patients.Graefes Arch Clin Exp Ophthalmol 2004;242:625-629
2. Maruko I, Iida T, Saito M, et al.Clinical characteristics of exudative age-related macular degeneration in Japanese patients.Am J Ophthalmol 2007;144:15-22
3. Lafaut BA, Leys AM, Snyers B, et al.Polypoidal choroidal vasculopathy in Caucasians.Graefes Arch Clin Exp Ophthalmol 2000;238:752-759
4. Cheng CK, Peng CH, Chang CK, et al.One-year outcomes of intravitreal bevacizumab (avastin) therapy for polypoidal choroidal vasculopathy.Retina 2011;31:846-856
5. Tsujikawa A, Ooto S, Yamashiro K, et al.Treatment of polypoidal choroidal vasculopathy by intravitreal injection of bevacizumab.Jpn J Ophthalmol 2010;54:310-319
6. Laude A, Cackett PD, Vithana EN, et al.Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: Same or different disease? Prog Retin Eye Res 2010;29: 19-29
7. Kondo N, Honda S, Ishibashi K, et al.Elastin gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.Invest Ophthalmol Vis Sci 2008;49:1101-1105
8. Fuse N, Mengkegale M, Miyazawa A, et al.Polymorphisms in ARMS2 (LOC387715) and LOXL1 genes in the Japanese with age-related macular degeneration.Am J Ophthalmol 2011;151: 550-556.e1
9. Sakurada Y, Mabuchi F, Yoneyama S, et al.Polymorphisms in ARMS2 (LOC387715) and LOXL1 genes in the Japanese with age-related macular degeneration.Am J Ophthalmol 2011;152: 499
10. Hogg RE, Woodside JV, Gilchrist SE, et al.Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology 2008;115:1046-1052.e2
11. Klein R, Klein BE, Tomany SC, Cruickshanks KJ.The association of cardiovascular disease with the long-Term incidence of age-related maculopathy: The Beaver Dam Eye Study.Ophthalmology 2003;110:636-643
12. Sun C, Klein R, Wong TY.Age-related macular degeneration and risk of coronary heart disease and stroke: The Cardiovascular Health Study.Ophthalmology 2009;116:1913-1919
13. Hu CC, Ho JD, Lin HC.Neovascular age-related macular degeneration and the risk of stroke: A 5-year population-based follow-up study.Stroke 2010;41:613-617
14. Topouzis F, Anastasopoulos E, Augood C, et al.Association of diabetes with age-related macular degeneration in the EUREYE study.Br J Ophthalmol 2009;93:1037-1041
15. Clemons TE, Milton RC, Klein R, et al.Risk factors for the incidence of advanced age-related macular degeneration in the age-related eye disease study (AREDS) AREDS report no.19.Ophthalmology 2005;112:533-539
16. Liew G, Mitchell P, Wong TY, et al.CKD increases the risk of age-related macular degeneration.J Am Soc Nephrol 2008;19: 806-811
17. Nitsch D, Evans J, Roderick PJ, et al.Associations between chronic kidney disease and age-related macular degeneration.Ophthalmic Epidemiol 2009;16:181-186
18. Ueta T, Obata R, Inoue Y, et al.Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.Ophthalmology 2009;116:2400-2406
19. Wilkinson CP, Ferris FL III, Klein RE, et al.Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.Ophthalmology 2003;110:1677-1682
20. Mori K, Horie-Inoue K, Gehlbach PL, et al.Phenotype and genotype characteristics of age-related macular degeneration in a Japanese population.Ophthalmology 2010;117:928-938
21. Ohmura T, Ueda K, Kiyohara Y, et al.Prevalence of type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: The Hisayama Study.Diabetologia 1993;36:1198-1203
22. Fujishima M, Kiyohara Y, Kato I, et al.Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study.Diabetes 1996;45:S14-S16
23. Mahdy RA, Nada WM.Evaluation of the role of vascular endothelial growth factor in diabetic retinopathy.Ophthalmic Res 2011;45:87-91
24. Zhang X, Saaddine JB, Chou CF, et al.Prevalence of diabetic retinopathy in the United States, 2005-2008.JAMA 2010;304: 649-656
25. Tong JP, Chan WM, Liu DT, et al.Aqueous humor levels of vascular endothelial growth factor and pigment epitheliumderived factor in polypoidal choroidal vasculopathy and choroidal neovascularization.Am J Ophthalmol 2006;141:456-462
26. Matsuo S, Imai E, Horio M, et al.Revised equations for estimated GFR from serum creatinine in Japan.Am J Kidney Dis 2009;53:982-992
27. The Japanese Society for Dialysis Therapy Home Page [in Japanese].Available at: Http://www.jst.or.jp.Accessed on July 20, 2011
28. Pawlak K, Mysliwiec M, Pawlak D.Oxidative stress, phosphate and creatinine levels are independently associated with vascular endothelial growth factor levels in patients with chronic renal failure.Cytokine 2008;43:98-101
29. Pawlak K, Pawlak D, Mysliwiec M.Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with endstage renal disease.Clin Biochem 2007;40:81-85
30. Vrabec R, Vatavuk Z, Pavlovic D, et al.Ocular findings in patients with chronic renal failure undergoing haemodialysis.Coll Antropol 2005;29:95-98
31. Nitsch D, Douglas I, Smeeth L, Fletcher A.Age-related macular degeneration and complement activation-related diseases: A population-based case-control study.Ophthalmology 2008; 115:1904-1910
32. Leys A, Vanrenterghem Y, Van Damme B, et al.Fundus changes in membranoproliferative glomerulonephritis type II.A fluorescein angiographic study of 23 patients.Graefes Arch Clin Exp Ophthalmol 1991;229:406-410